Anxiety-like behaviour is attenuated by gabapentin, morphine and diazepam in a rodent model of HIV anti-retroviral-associated neuropathic pain
暂无分享,去创建一个
Andrew S.C. Rice | Andrew R. Segerdahl | A. Rice | V. Wallace | A. Segerdahl | Julie Blackbeard | Timothy Pheby | Victoria C.J. Wallace | T. Pheby | J. Blackbeard
[1] E. Rüther,et al. Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam , 2008, Behavioural pharmacology.
[2] J. Breuer,et al. Further characterization of a rat model of varicella zoster virus–associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs , 2007, Neuroscience.
[3] J. Desmeules,et al. Differential action of morphine and various opioid agonists on thermal allodynia and hyperalgesia in mononeuropathic rats , 1994, Pain.
[4] Ronald Dubner,et al. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury , 1990, Pain.
[5] J. Quinn,et al. Behavioural changes in the rat following infection with varicella-zoster virus. , 1999, The Journal of general virology.
[6] A. Holmes,et al. Mechanical and cold hypersensitivity in nerve-injured C57BL/6J mice is not associated with fear-avoidance- and depression-related behaviour. , 2007, British journal of anaesthesia.
[7] Salahadin Abdi,et al. The Anti-Allodynic Effects of Amitriptyline, Gabapentin, and Lidocaine in a Rat Model of Neuropathic Pain , 1998, Anesthesia and analgesia.
[8] Jin Mo Chung,et al. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat , 1992, PAIN.
[9] K. Ä. Möller,et al. Assessing mechanical allodynia in the rat paw with a new electronic algometer , 1998, Journal of Neuroscience Methods.
[10] H. Anderson,et al. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs , 2005, Pain.
[11] M. Maschke,et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies , 2004, Journal of Neurology.
[12] C. Woolf,et al. Spared nerve injury: an animal model of persistent peripheral neuropathic pain , 2000, Pain.
[13] J. Ochoa,et al. NEUROPATHIC PAIN: REDEFINITION AND A GRADING SYSTEM FOR CLINICAL AND RESEARCH PURPOSES , 2009, Neurology.
[14] Andrew R Segerdahl,et al. Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. , 2007, Brain : a journal of neurology.
[15] J. Herman,et al. Limbic and HPA axis function in an animal model of chronic neuropathic pain , 2006, Physiology & Behavior.
[16] T. Nurmikko,et al. Analgesic Therapy in Postherpetic Neuralgia: A Quantitative Systematic Review , 2005, PLoS medicine.
[17] Andrew S.C. Rice,et al. Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy , 2007, PAIN®.
[18] M. Bourin. Animal models of anxiety: are they suitable for predicting drug action in humans? , 1997, Polish journal of pharmacology.
[19] J. de Vry,et al. Pharmacological characterization of the chronic constriction injury model of neuropathic pain. , 2004, European journal of pharmacology.
[20] A. Dickenson,et al. Gabapentin Normalizes Spinal Neuronal Responses That Correlate with Behavior in a Rat Model of Cancer-induced Bone Pain , 2005, Anesthesiology.
[21] M. Backonja,et al. The effect of continuous morphine analgesia on chronic thermal hyperalgesia due to sciatic constriction injury in rats , 1995, Neuroscience Letters.
[22] Rolf-Detlef Treede,et al. Anxiety-like behaviour in rats with mononeuropathy is reduced by the analgesic drugs morphine and gabapentin , 2008, PAIN.
[23] John F. Cryan,et al. Model organisms: The ascent of mouse: advances in modelling human depression and anxiety , 2005, Nature Reviews Drug Discovery.
[24] R. J. Leo. Chronic pain and comorbid depression , 2005, Current treatment options in neurology.
[25] Klaus-Peter Lesch,et al. Mice Lacking the Serotonin Transporter Exhibit 5-HT1A Receptor-Mediated Abnormalities in Tests for Anxiety-like Behavior , 2003, Neuropsychopharmacology.
[26] J. Farrar,et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations , 2003, Pain.
[27] N. B. Finnerupa,et al. Algorithm for neuropathic pain treatment: An evidence based proposal , 2005 .
[28] M. Zimmermann,et al. Ethical guidelines for investigations of experimental pain in conscious animals , 1983, Pain.
[29] J. Turner,et al. Chronic pain and depression: does the evidence support a relationship? , 1985, Psychological bulletin.
[30] R. Gallagher,et al. The psychopharmacologic treatment of depression and anxiety in the context of chronic pain , 2002, Current pain and headache reports.
[31] S. Verma,et al. Comorbidities in chronic neuropathic pain. , 2004, Pain medicine.
[32] R. Gallagher,et al. Managing pain and comorbid depression: A public health challenge. , 1999, Seminars in clinical neuropsychiatry.
[33] D. Cottrell,et al. Focal Lysolecithin-Induced Demyelination of Peripheral Afferents Results in Neuropathic Pain Behavior That Is Attenuated by Cannabinoids , 2003, The Journal of Neuroscience.
[34] A. Rice,et al. Comparison of psychological and physical function in neuropathic pain and nociceptive pain: Implications for cognitive behavioral pain management programs , 2008, European journal of pain.
[35] H. J. McQuay,et al. Algorithm for neuropathic pain treatment: An evidence based proposal , 2005, Pain.
[36] T. Gordh,et al. Peripheral neuropathic pain—a multidimensional burden for patients , 2001, European journal of pain.
[37] Tomoe Takagi,et al. Usefulness of Antidepressants for Improving the Neuropathic Pain-Like State and Pain-Induced Anxiety through Actions at Different Brain Sites , 2008, Neuropsychopharmacology.
[38] A. Rice,et al. The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L‐29) on pain behaviour in rodent models of neuropathy , 2007, British journal of pharmacology.
[39] J. Levine,et al. Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat , 2004, Pain.
[40] Blair H. Smith,et al. Health and Quality of Life Associated With Chronic Pain of Predominantly Neuropathic Origin in the Community , 2007, The Clinical journal of pain.